A booklet for you to give to your patients who have been prescribed GILENYA. The booklet provides background information about GILENYA, important information about taking GILENYA, and practical advice about wellbeing while on treatment. If you would like to receive copies of any of these materials, please contact your Key Account Manager.
Gd+: gadolinium enhancing; MRI: magnetic resonance imaging; RES: rapidly evolving severe; RRMS: relapsing remitting multiple sclerosis.
Indication: GILENYA is indicated as a single disease modifying therapy in highly active RRMS for the following groups of adult patients and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with ≥1 disease modifying therapy, or patients with RES RRMS deﬁned by ≥2 disabling relapses in 1 year, and with 1 or more Gd+ lesions on brain MRI or a signiﬁcant increase in T2 lesion load as compared to a previous recent MRI.1
- GILENYA (fingolimod) Summary of Product Characteristics.